STATE OF WISCONSIN INVESTMENT BOARD - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 201 filers reported holding REATA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.11 and the average weighting 0.6%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$2,797,477
+27.0%
27,437
+13.2%
0.01%
+14.3%
Q1 2023$2,203,083
+115.2%
24,231
-10.1%
0.01%
+133.3%
Q4 2022$1,023,717
-30.4%
26,947
-53.9%
0.00%
-40.0%
Q3 2022$1,470,000
+77.5%
58,499
+114.7%
0.01%
+150.0%
Q2 2022$828,000
-29.4%
27,252
-23.9%
0.00%0.0%
Q1 2022$1,173,000
+24.3%
35,8000.0%0.00%0.0%
Q4 2021$944,000
-73.8%
35,8000.0%0.00%
-71.4%
Q3 2021$3,602,000
-26.7%
35,800
+3.2%
0.01%
-30.0%
Q2 2021$4,911,000
+1366.0%
34,700
+932.4%
0.01%
+900.0%
Q1 2021$335,000
-12.3%
3,361
+8.8%
0.00%0.0%
Q4 2020$382,000
+21.7%
3,090
-4.0%
0.00%0.0%
Q3 2020$314,000
-42.7%
3,220
-8.3%
0.00%
-50.0%
Q2 2020$548,000
-89.2%
3,510
-90.0%
0.00%
-88.2%
Q1 2020$5,052,000
-17.9%
35,000
+16.3%
0.02%
+13.3%
Q4 2019$6,153,000
+154.6%
30,1000.0%0.02%
+114.3%
Q3 2019$2,417,000
-6.5%
30,100
+9.9%
0.01%0.0%
Q2 2019$2,585,000
+22.9%
27,400
+11.4%
0.01%
+16.7%
Q1 2019$2,103,000
+97.3%
24,600
+29.5%
0.01%
+100.0%
Q4 2018$1,066,000
-19.5%
19,000
+17.3%
0.00%
-25.0%
Q3 2018$1,325,000
+133.7%
16,2000.0%0.00%
+100.0%
Q2 2018$567,00016,2000.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Conrad N. Hilton Foundation 63,481$7,847,000100.00%
CPMG Inc 2,896,901$358,115,00055.16%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 140,000$17,307,00026.62%
Corriente Advisors, LLC 525,000$64,901,00015.45%
DUMAC, INC. 76,050$9,401,0007.33%
MADDEN SECURITIES Corp 35,152$4,345,0002.80%
Biondo Investment Advisors, LLC 113,692$14,055,0002.69%
Duquesne Family Office 749,897$92,702,0002.50%
LBJ Family Wealth Advisors, Ltd. 30,368$3,754,0002.44%
Integral Health Asset Management, LLC 50,000$6,181,0001.84%
View complete list of REATA PHARMACEUTICALS INC shareholders